Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-018916
Filing Date
2017-07-25
Accepted
2017-07-25 17:08:15
Documents
2
Period of Report
2017-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2212
2 EX-24 DOCUMENT attachment1.htm EX-24 4214
  Complete submission text file 0000899243-17-018916.txt   7909
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PANACOS PHARMACEUTICALS, INC. 134 COOLIDGE AVENUE WATERTOWN MA 02472
Business Address
Fischer Laurent (Reporting) CIK: 0001379344 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-28386 | Film No.: 17981036